Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Oct 6;12(10):1563-1565.
doi: 10.2215/CJN.07620717. Epub 2017 Sep 7.

Contemporary Management of Hepatitis C in Patients with CKD

Richard J Johnson  1 , Michiko Shimada  2
Affiliations
Editorial

Contemporary Management of Hepatitis C in Patients with CKD

Richard J Johnson et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: Disease Management; Hepacivirus; Hepatitis C; Humans; Renal Insufficiency, Chronic.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic of hepatitis C virus and classification of direct-acting antiviral agents.
See this image and copyright information in PMC

Comment on

References

    1. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE, Willson R: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328: 465–470, 1993 - PubMed
    1. Molnar MZ, Alhourani HM, Wall BM, Lu JL, Streja E, Kalantar-Zadeh K, Kovesdy CP: Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans. Hepatology 61: 1495–1502, 2015 - PMC - PubMed
    1. Fabrizi F, Verdesca S, Messa P, Martin P: Hepatitis C virus infection increases the risk of developing chronic kidney disease: A systematic review and meta-analysis. Dig Dis Sci 60: 3801–3813, 2015 - PubMed
    1. Lawitz E, Sulkowsk, Ghalib R, Rodriguez-Torres M, Younossi ZM, Corregidor A, DeJesus E, Pearlman B, Rabinovitz M, Gitlin N, Lim JK, Pockros PJ, Scott JD, Fevery B, Lambrecht T, Ouwerkerk-Mahadevan S, Callewaert K, Symonds WT, Picchio G, Lindsay KL, Beumont M, Jacobson IM: Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: The COSMOS randomised study. Lancet 384: 1756–1765, 2014 - PubMed
    1. Jensen CM, Holle LM: Ledipasvir-Sofosbuvir: A once-daily oral treatment option for chronic hepatitis C virus genotype 1 infection. Pharmacotherapy 36: 562–574, 2016 - PubMed